BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 28247041)

  • 1. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests.
    Sukul P; Schubert JK; Oertel P; Kamysek S; Taunk K; Trefz P; Miekisch W
    Sci Rep; 2016 Jun; 6():28029. PubMed ID: 27311826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of breath VOCs and electrical impedance tomography under pulmonary recruitment in mechanically ventilated patients.
    Brock B; Kamysek S; Silz J; Trefz P; Schubert JK; Miekisch W
    J Breath Res; 2017 Jan; 11(1):016005. PubMed ID: 28068288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
    Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
    J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
    Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
    Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the determination of isoprene in human breath using substrate-integrated hollow waveguide mid-infrared sensors.
    Perez-Guaita D; Kokoric V; Wilk A; Garrigues S; Mizaikoff B
    J Breath Res; 2014 Jun; 8(2):026003. PubMed ID: 24848160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath.
    Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA
    Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atmospheric pressure chemical ionization mass spectrometry of pyridine and isoprene: potential breath exposure and disease biomarkers.
    Kapishon V; Koyanagi GK; Blagojevic V; Bohme DK
    J Breath Res; 2013 Jun; 7(2):026005. PubMed ID: 23579200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study.
    King J; Mochalski P; Kupferthaler A; Unterkofler K; Koc H; Filipiak W; Teschl S; Hinterhuber H; Amann A
    Physiol Meas; 2010 Sep; 31(9):1169-84. PubMed ID: 20664160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus.
    Grabowska-Polanowska B; Skowron M; Miarka P; Pietrzycka A; Śliwka I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():103-110. PubMed ID: 28605624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease.
    Meinardi S; Jin KB; Barletta B; Blake DR; Vaziri ND
    Biochim Biophys Acta; 2013 Mar; 1830(3):2531-7. PubMed ID: 23274524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of volatile organic compounds indicative of human presence in the air.
    Kwak J; Geier BA; Fan M; Gogate SA; Rinehardt SA; Watts BS; Grigsby CC; Ott DK
    J Sep Sci; 2015 Jul; 38(14):2463-9. PubMed ID: 25944350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
    Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
    Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.